Colo. Rev. Stat. § 12-245-301

Current through Chapter 492 of the 2024 Legislative Session

Section 12-245-301 - Definitions

As used in this part 3, unless the context otherwise requires:

(1) "Adverse action" means any action taken by the board that finds a violation of a statute or rule that is identified by the board as discipline and is a matter of public record.

(2) "Approved school" means any university or other institution of higher education offering a full-time graduate course of study in psychology and having programs approved by the American Psychological Association or the board.

(3) "Board" means the state board of psychologist examiners created by section 12-245-302 (1).

(4) "Independently licensed prescribing physician" means a physician licensed pursuant to article 240 of this title 12 who supervises licensed psychologists participating in practicums described in section 12-245-309 (2)(a)(IV).

(5) "Licensed psychologist" means a person licensed pursuant to this part 3.

(6) "Narcotic drug" has the same meaning as set forth in section 18-18-102 (20).

(7) "Prescribing psychologist" means a licensed psychologist who holds a prescription certificate.

(8) "Prescription certificate" means a document issued by the board, with approval of the Colorado medical board, to a licensed psychologist that permits the licensed psychologist to prescribe psychotropic medications pursuant to this part 3.

(9) "Professional psychological training program" means a doctoral training program that:

(a) Is a planned program of study that reflects an integration of the science and practice of psychology; and

(b) For applicants receiving their terminal degrees after 1990, is designated as a doctoral program in psychology by the Association of State and Provincial Psychology Boards or the National Register of Health Service Psychologists or is accredited by the American Psychological Association or Canadian Psychological Association.

(10)

(a) "Psychotropic medication" means a controlled substance or dangerous drug:

(I) That may not be dispensed or administered without a prescription;

(II) For which the primary indication for use is approved by the federal food and drug administration for the treatment of mental health disorders; and

(III) That is listed as a psychotherapeutic agent in the most recent edition of "Drug Facts and Comparisons" or in the American hospital formulary service drug information compendium.

(b) "Psychotropic medication" does not include a narcotic drug.

(11) "Telepsychology" means the provision of psychological services using telecommunications technologies.

C.R.S. § 12-245-301

Amended by 2023 Ch. 6, § 3, eff. 8/7/2023.

Renumbered from C.R.S. § 12-43-301 and amended by 2019 Ch. 136, § 1, eff. 10/1/2019.

Amended by 2018 Ch. 133, § 2, eff. 8/8/2018.

L. 98: Entire part R&RE, p. 1128, § 19, effective July 1. L. 2011: (3), (5), and (7) repealed, (SB 11 -187), ch. 285, p. 1311, § 39, effective July 1. L. 2018: (1) amended and (1.5) and (9) added, (HB 18-1017), ch. 133, p. 884, § 2, effective August 8.

This section is similar to former § 12-43-301 as it existed prior to 2019.

2023 Ch. 6, was passed without a safety clause. See Colo. Const. art. V, § 1(3).